C. Fernández-Reino, N. Fernández-Díaz, N. González-García, M. Giráldez-Martínez, U. Anido-Herranz, P. Freijido-Álvarez, J. Ruíz-Bañobre, L. León-Mateos.
{"title":"Biomarcadores moleculares y celulares en los tumores genitourinarios, implicaciones terapéuticas","authors":"C. Fernández-Reino, N. Fernández-Díaz, N. González-García, M. Giráldez-Martínez, U. Anido-Herranz, P. Freijido-Álvarez, J. Ruíz-Bañobre, L. León-Mateos.","doi":"10.1016/j.med.2025.02.008","DOIUrl":null,"url":null,"abstract":"<div><div>A biomarker is a measurable characteristic that provides information about a biological or pathological state or a response to a treatment. Predictive biomarkers inform us about the probability of response to a specific treatment. As oncology moves towards tumor molecular characterization and histology becomes less important, biomarkers are gaining importance in therapeutic decision making. This protocol summarizes the main recommendations regarding the determination of these markers in genitourinary tumors and their therapeutic implications.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 26","pages":"Pages 1566-1569"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225000381","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A biomarker is a measurable characteristic that provides information about a biological or pathological state or a response to a treatment. Predictive biomarkers inform us about the probability of response to a specific treatment. As oncology moves towards tumor molecular characterization and histology becomes less important, biomarkers are gaining importance in therapeutic decision making. This protocol summarizes the main recommendations regarding the determination of these markers in genitourinary tumors and their therapeutic implications.